GeneMind Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 18

GeneMind General Information

Description

Manufacturer of DNA sequencing systems intended to facilitate precision medical diagnostics and genomic research. The company's technology uses surface-restricted fluorescence sequencing, patterned array flow cells, and artificial intelligence-based recognition algorithms to provide medical institutions with high-throughput sequencers, automated nucleic acid extractors, and sample preparation systems, enabling accurate genetic analysis and molecular profiling for oncology, reproductive health, and infectious disease monitoring.

Contact Information

Website
www.genemind.com
Formerly Known As
Shenzhen HanHai Gene Biotechnology, Direct Genomics Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 5th and 6th Floors, Tower 2, Luohu Investment Holding Building
  • Number 112, Qingshuihe 1st Road, Luohu District
  • Shenzhen, Guangdong 518004
  • China
+86 400
Primary Industry
Diagnostic Equipment
Vertical(s)
Manufacturing
Corporate Office
  • 5th and 6th Floors, Tower 2, Luohu Investment Holding Building
  • Number 112, Qingshuihe 1st Road, Luohu District
  • Shenzhen, Guangdong 518004
  • China
+86 400

GeneMind Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneMind Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GeneMind‘s full profile, request access.

Request a free trial

GeneMind Patents

  • 331

    Total Documents Applications and Grants

  • Total Patents Families

  • 117

    Granted

  • 155

    Pending

  • Expiring in next 12 mo

GeneMind Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4837656-A1 Liquid path system and method for controlling same Pending 28-Apr-2026
US-20260355711-A1 Liquid path system and method for controlling same Pending 07-May-2025
US-20260347931-A1 Two-color sequencing method and kit Pending 16-Apr-2025
EP-4814482-A1 Sample analysis device and method for controlling same Pending 27-Mar-2025
US-20260298869-A1 Sample analysis device and method for controlling same Pending 27-Mar-2025 G01N27/44756
To view GeneMind’s complete patent history, request access »

GeneMind Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GeneMind‘s full profile, request access.

Request a free trial

GeneMind FAQs

  • When was GeneMind founded?

    GeneMind was founded in 2012.

  • Where is GeneMind headquartered?

    GeneMind is headquartered in Shenzhen, China.

  • What industry is GeneMind in?

    GeneMind’s primary industry is Diagnostic Equipment.

  • Is GeneMind a private or public company?

    GeneMind is a Private company.

  • What is GeneMind’s current revenue?

    The current revenue for GeneMind is .

  • How much funding has GeneMind raised over time?

    GeneMind has raised $273M.

  • Who are GeneMind’s investors?

    Delian Capital, Guangxi Investment Group, Guosheng Hongyuan Private Equity, Guoxin Science and Technology Innovation Fund Management, and Hunan Chasing Fund are 5 of 31 investors who have invested in GeneMind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process